U.S. pressure of reference drug pricing system senseless.

Published: 2006-03-15 06:56:00

Updated: 2006-03-15 06:56:00

The MOHW made it clear on some earlier press reports that the participation of a U. S. embassy official to the MOHW's drug working group's meeting and the issue on the implementation holding of the reference drug pricing system had nothing to do with the pressure of the U. S. government.

The ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK